Skip to content

Improving safety and quality: psychosocial influences of managing medicines by consumers with chronic health problems

Consumers with diabetes and kidney disease: a nurse-led intervention to improve medication adherence

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000044426
Acronym
MESMI
Enrollment
144
Registered
2007-01-12
Start date
2008-08-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Australians are experiencing an increased prevalence of chronic diseases which require sustained self-management of medicines and long term monitoring by health professionals. The proposed study will determine the psychosocial influences affecting self-management of medicines by consumers with co-existing chronic diseases, specifically diabetes, kidney disease and hypertension. The aims of the study are to develop and test the effectiveness of a medicine self-management training package (MESMI). Null hypothesis: Compared to patients receiving standard care, patients who receive the intervention will show no change in blood pressure

Interventions

A DVD will be shown to participants during the home visit. There is only one planned home visit in the 12-week period. The DVD will contain health information for consumers regarding medicines in relation to their chronic conditions to enhance decision-making and behavioural change. Patients will be taught how to take their blood pressure using an electronic self-monitoring blood pressure machine during the home visit. A medication review will be conducted at this time, which will involve checki

A DVD will be shown to participants during the home visit. There is only one planned home visit in the 12-week period. The DVD will contain health information for consumers regarding medicines in relation to their chronic conditions to enhance decision-making and behavioural change. Patients will be taught how to take their blood pressure using an electronic self-monitoring blood pressure machine during the home visit. A medication review will be conducted at this time, which will involve checking the medication regimen with the patient to reach agreement about their treatment and development of a tailored drug chart for the patient. Fortnightly follow-up telephone calls will be made thereafter to the patients for 12 weeks. The intervention will be 12 weeks in total.

Sponsors

The University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Mentally competent Australians Comprehend English Diabetes, kidney disease and systolic hypertension treated with antihypertensive medication

Exclusion criteria

Imminent end stage kidney disease (ESKD) Pregnancy Aggressive form of cancer Mental illness not stabilised with medication

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 1, 2026